Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misoprostol versus expectant management for retained products of conception
IRCT20240514061800N3Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of misoprostol in retained placenta and abortion (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Improvement of menstrual intervals as well as vaginal bleeding. Started Sep 2024; status: completed.
02
Drugs
misoprostol
03
Conditions
retained placentaabortion
Beyond the preview
Go deeper on IRCT20240514061800N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240514061800N3.